HIKAL LIMITED
HIKAL · General/Diversified · NSE
₹181
Current Market Price
Fair Value (DCF)
₹154
Margin of Safety
-15.2%
Updated just now
YieldIQ Score
58/100
Piotroski F-Score
8/9
Economic Moat
Narrow
Confidence
40%
ROE
—
Debt/Equity
0.00
WACC
11.1%
Market Cap
₹2,233 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
11.3%
Return on capital employed
EV / EBITDA
—
Enterprise multiple
Debt / EBITDA
3.4×
Leverage vs earnings
Interest Coverage
2.7×
EBIT covers interest
Current Ratio
1.26×
Short-term liquidity
Asset Turnover
0.73×
Revenue per ₹ of assets
Revenue CAGR (3Y)
-1.5%
3-year revenue growth
Revenue CAGR (5Y)
—
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹181.1
Bear case
₹81.15
MoS -123.2%
Base case
₹153.64
MoS -17.9%
Bull case
₹213.66
MoS +15.2%
Ratio Trends
HIKAL · last 8 annual periods
ROE
7.2%
ROCE
16.3%
Operating Margin
—
Debt / Equity
0.61×
PE
96.5×
EV / EBITDA
14.5×
Historical Financials
HIKAL · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹1720 Cr | ₹1926 Cr | ₹2005 Cr | ₹1769 Cr | ₹1844 Cr | +1.7% |
| EBITDA | — | ₹340 Cr | ₹255 Cr | ₹266 Cr | ₹331 Cr | -0.7% |
| EBIT | ₹243 Cr | — | ₹61.6 Cr | ₹62.6 Cr | — | -28.7% |
| PAT | ₹133 Cr | ₹160 Cr | ₹78.4 Cr | ₹69.6 Cr | ₹90.8 Cr | -9.1% |
| EPS (diluted) | ₹10.80 | — | ₹2.92 | ₹2.76 | — | -28.9% |
| CFO | ₹229 Cr | ₹294 Cr | ₹315 Cr | ₹187 Cr | ₹280 Cr | +5.2% |
| CapEx | — | ₹-273 Cr | — | — | ₹-137 Cr | — |
| FCF | — | ₹20.4 Cr | — | — | ₹143 Cr | +62.7% |
| Total Assets | — | ₹2213 Cr | ₹2385 Cr | ₹2487 Cr | ₹2529 Cr | +3.4% |
| Total Debt | — | ₹675 Cr | ₹258 Cr | ₹392 Cr | ₹765 Cr | +3.2% |
| Shareholders' Equity | — | ₹1068 Cr | ₹1133 Cr | ₹1188 Cr | ₹1262 Cr | +4.3% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
HIKAL vs 5 closest peers by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
| SOLARA SOLARA ACTIVE PHA SCI LTD | +106.8% | 75 | Undervalued | 0.0% | — |
| MOREPENLAB MOREPENLAB | — | — | Pending | 9.9% | — |
| UNICHEMLAB UNICHEMLAB | — | — | Pending | 5.6% | — |
| IOLCP IOLCP | — | — | Pending | 6.0% | — |
| BLISSGVS BLISSGVS | — | — | Pending | 7.7% | — |
Click a ticker to view its fair-value analysis.
Dividend History
No dividend events recorded for HIKAL in the last 10 years.
AI Analysis Summary
Model-generated description of metrics. Not investment advice. HIKAL LIMITED (HIKAL.NS) trades at 181.10 vs a model fair value of 153.64, a gap of -15.2%. Piotroski F-score: 8/9. Moat label: Narrow. R...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of HIKAL →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for HIKAL →
Compare
Head-to-head with peers
Compare HIKAL side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse HIKALNow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.